What a crock of bullS#*%...I have owned shares of Dendreon, Elan, Allos, and Amlyn Pharmaceutical. Each of those companies experienced their own lumps w/FDA; each went through Advisory Panels (some multiple times)...and each was approved ultimately by FDA. With the exception of Allos (misjudged the market), each experienced a significant price increase after FDA approval. Anyone w/experience in Phase III drug trials/FDA oversight knew that an Advisory Panel was forthcoming. FDA will almost certainly follow its lead. Disclosure: Long 16+K shares and smiling :)
That's pretty close to the most inane post I've ever read. You've yet to find a drug where an Adcom was a good thing? Really? How long did you research this, 20 seconds before writing that absolutely stupid post?
FDA follow Adcom advice 80-90% of the time. Kevin is an idiot - but he's proven that time and again with his whining. I think the mlk at the end of his screen name stands for Mothers Little Kuddlebunny.